Navigation Links
Society of Interventional Radiology: Pioneering specialty reaches out
Date:2/28/2013

FAIRFAX, Va., Feb. 28, 2013 /PRNewswire-USNewswire/ -- Online meeting registration is open for the Society of Interventional Radiology's Annual Scientific Meeting April 13–18 at the Ernest N. Morial Convention Center in New Orleans.

(Logo: http://photos.prnewswire.com/prnh/20100127/SIRLOGO)

"The meeting's theme, 'IR Reaching Out,' illustrates the many ways the Annual Scientific Meeting provides valuable education to attendees across a broad range of diverse clinical interests and practice settings," said Gary P. Siskin , M.D., FSIR, the meeting's scientific program chair. "Annual Scientific Meeting attendees come from all areas: they are community or university-based physicians, physician assistants, nurse practitioners and radiology assistants, nurses, technologists, hospital administrators and industry partners. To complement our theme of inclusion, we've designed sessions that will meet the educational needs of all these various groups," said Siskin, who is professor and chair of the department of radiology at Albany Medical College, Albany, N.Y.

Approximately 5,300 attendees are expected to explore the latest interventional radiology research, evidence, techniques and technologies through a host of symposia, workshops and plenary and scientific sessions led by interventional radiology's key leaders. With "Prostate and Bladder Embolization," attendees will have the opportunity to review the current evidence on the use of embolization on the prostatic artery for the treatment of men's enlarged prostates. In "Renal Denervation: A Primer for Radiologists," experts will review the clinical evidence for this possible new way to treat hypertension, cardiac failure and other conditions. "Cosmetic IR: Going Beyond the Norm" explores the demand for minimally invasive cosmetic techniques. With insight from a diverse faculty that consists of academic and private practice interventional radiologists as well as physicians outside of the field, the "Future of IR" will examine the current state of interventional radiology and its short- and long-term outlook. 

Siskin noted that this year's meeting includes contributions from several SIR service lines, including interventional oncology, peripheral arterial disease, interventional neuroradiology and venous disease. "This is a successful model of collaboration that promotes interventional radiology's role across disease states and provides attendees with insight into the specialty's clinical and multidisciplinary nature among varied practice settings," said Siskin.

"Annual Scientific Meeting programming will include more evidence-driven, innovative sessions on each aspect of interventional radiology," said Siskin. "So many things combine to make this year's program our most comprehensive to date. For example, there is a concentration on issues and challenges inherent to community-based practice in the new 'In the Trenches' series and the opportunity to spend time with interventional radiology experts during 'Meet the Professors.' In 'SIR Global,' we'll provide insight into the unique contributions that our colleagues in South America are making to the specialty," he noted.

"SIR 2013 will feature 400 abstracts, including 237 oral presentations that will highlight state-of-the-art technology and research evidence of best practices in the management and treatment of disease processes across the spectrum of interventional radiology. These sessions will also include the most current research on clinical trials, evidence and innovation," noted Daniel B. Brown , M.D., FSIR, the meeting's scientific program chair and chief of interventional radiology and interventional oncology at Thomas Jefferson University Hospital in Philadelphia.

 The advanced registration deadline is March 8.  For more information about the Society of Interventional Radiology and/or to register for the 38th Annual Scientific Meeting, visit www.SIRweb.org or www.SIRmeeting.org.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. This year, SIR celebrates 40 years of innovation and advances in interventional radiology. Visit www.SIRweb.org.

The Society of Interventional Radiology is holding its 38th Annual Scientific Meeting April 13-18, 2013 at the Ernest N. Morial Convention Center in New Orleans. The theme of the meeting is 'IR Reaching Out,' adopted to illustrate the many ways the Annual Scientific Meeting provides valuable education to attendees with a broad range of diverse clinical interests and practice settings.


'/>"/>
SOURCE Society of Interventional Radiology
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
2. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
3. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
4. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
5. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
8. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
9. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
10. Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
11. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and ... the ultimate weight loss and wellness program, at their world headquarters of Omni La ... immediate and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):